Impact Factor
4.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
13.54
2,085 total citations
h5-index
53
h5 depth signal
Cited share
92.1%
151 of 164
Total citations
2,085
Citation footprint
Metric signal
16.91
External metric anchor
Self-citation
0.3%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
334
China
96
Germany
51
Italy
44
Australia
43
Citing Fields of Research
Oncology
289
Cancer & Development
254
Immunology
144
Cancer, Autophagy & Apoptosis
96
Breast Cancer
65
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,126
Articles tracked across the journal lifetime
Indexed publication set
164
151 cited publications
Last 12 months
89
7.4 publications/month
Open access share
60.7%
54 OA publications in the last year
Leading citing country
United States
334 citing publications
Leading citing field
Oncology
289 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1982-
v1n1, 1982-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Oncology
Cancer & Development
Lung Cancer
Cancer, Autophagy & Apoptosis
Broad Categories
Neoplasms
Cancer & Development
Immunology
Cancer, Autophagy & Apoptosis
Noncoding RNA
Lung Cancer
Immunotherapy
MeSH Descriptors
Neoplasm Metastasis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10555-026-10385-4
Open DOI
Histotype and molecular subtype integration in epithelial ovarian cancer: implications for targeted treatment
02
03
DOI 10.1007/s10555-026-10384-5
Open DOI
Thymic epithelial tumors: what’s next?
Thymic epithelial tumors (TETs) are rare malignancies arising in an organ central to T cell development and immune tolerance, creating a distinctive interface between tumor biology and immunotherapy. Complete surgical resection remains t...
04
DOI 10.1007/s10555-026-10383-6
Open DOI
Mechanisms of systemic immune modulation in tumor development: Interactions across lymph nodes, bone marrow, and blood
Cancer is a systemic disease in which the tumor interacts with the entirety of the body to promote tumor pathogenesis and progression. While tremendous efforts have focused on understanding the local immune responses in the primary site ...
05
DOI 10.1007/s10555-026-10382-7
Open DOI
Extracellular vesicles in breast cancer metastasis: functional insights and advances in single-EV analysis
Breast cancer (BC) metastasis remains a leading cause of mortality despite significant advances in screening and diagnosis. Extracellular vesicles (EVs), secreted by all living cells, carry biologically active cargo such as RNAs and prot...
06
DOI 10.1007/s10555-026-10380-9
Open DOI
The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications
Homologous recombination deficiency (HRD) is a major genomic feature of several malignancies and provides a therapeutic rationale for DNA-damaging agents and PARP inhibitors. Beyond its role in genome instability, accumulating evidence s...
07
DOI 10.1007/s10555-026-10377-4
Open DOI
Extracellular vesicles shape tumourigenesis: from signalling networks to systemic progression
Extracellular vesicles (EVs) are established mediators of long-range intercellular communication in cancer, transferring oncogenic and regulatory cargo that reshapes recipient cells across tissues. Recent integrative multi-omics analyses...
08
DOI 10.1007/s10555-026-10381-8
Open DOI
Precision therapeutic strategies for advanced gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GISTs), the most common mesenchymal neoplasms of the gastrointestinal tract, are molecularly heterogeneous diseases rather than a single entity. Activating mutations in KIT and PDGFRA define the dominant ...
09
10
DOI 10.1007/s10555-026-10374-7
Open DOI
Circulating Cell-free DNA as a biomarker for radiation-induced injury: From mechanistic insights to clinical translation
Bibliographical & Catalog Notes
Issues for 1985- have title: Cancer and metastasis reviews.
Also issued online.
Vol. 8, no. 1 (1989)19921001 Notice published Printed on acid-free paper